In summary, research studies to date have not identified a unitary cause of MS; rather, genetic
predisposition (particularly, inherited immunoregulatory abnormalities) and environmental …

Multiple sclerosis (MS) is thought by many investigators to have an infectious component,
and several microorganisms have been associated with the disease during the last three …

… overt disease, defined as primary progressive multiple sclerosis (PPMS). Despite early …
review, except where defined, SPMS and PPMS will be grouped as progressive multiple sclerosis …

… issues is briefly reviewed with critical commentary, … multiple sclerosis (MS) has been known
since Charcot gave the first detailed clinicopathological description of “disseminated sclerosis…

… This review summarizes Phase III clinical trial data available for fingolimod. The main … the
first oral compound available for treatment of multiple sclerosis (MS) and just recently approved …

… be a highly efficient process in multiple sclerosis. However, in the … -term disability in patients
with multiple sclerosis. For this reason, … In this editorial we casts a critical eye over the most …

… Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and
… Central to immunity and critically important for human health, KIR molecules and their HLA …

… Application of the 2017 revised McDonald Criteria for multiple sclerosis to patients with a
typical … This review summarizes current evidence regarding diagnosis and treatment of MS. …

… Because mortality data are inadequate to give an accurate picture of a disease with the
clinical characteristics of multiple sclerosis (MS) 111, the spatial and temporal distribution of MS …

This review discusses type I interferon (IFN) immunogenicity with focus on methods of detection
of anti-IFN antibodies in patients treated with human recombinant IFN-β. Pitfalls involved …